UK markets open in 3 hours 27 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,402.63 +195.50 (+1.07%) CRUDE OIL
79.15 +0.20 (+0.25%) GOLD FUTURES
2,309.70 +0.10 (+0.00%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,622.93 +1,727.88 (+3.76%)
Codexis, Inc. (0I0X.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 07:13PM BST
| Previous close | 3.1000 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 21,109 |
| Market cap | 1.584M |
| Beta (5Y monthly) | 2.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3180 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Codexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic Advances
Despite a Net Loss, Codexis Demonstrates Strong Revenue Growth and Strategic Milestones
GlobeNewswireCodexis Reports First Quarter 2024 Financial Results
Q1 Total Revenue Up 32% Year-over-year, Including Product Revenue Up 14%; Company Reiterates 2024 Financial Guidance First Substantial Order for dsRNA Ligase Received from Large Pharma Customer Company is in Final Stages of Enzymatically Synthesizing a Full-Length Oligonucleotide with ECO Synthesis™ Manufacturing Platform and will Provide Update at TIDES USA Meeting REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today an
Simply Wall St.With 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big guns
Key Insights Given the large stake in the stock by institutions, Codexis' stock price might be vulnerable to their...
© 2024 Yahoo. All rights reserved.